Juliette Lambert

13PUBLICATIONS
67CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Terahertz physicsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 27, 2026
Prognostic Impact of FLT3-ITD Allelic Ratio in AML Patients Treated With High-Dose Anthracycline and a FLT3 Inhibitor.

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|Mar 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez

|May 19, 2023
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.

Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert

|Apr 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia.

Nicolas Duployez, Loïc Vasseur, Rathana Kim

|Nov 14, 2022
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.

Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Bérard

Pageof 3

Frequent Collaborators

10 joint publications

Nicolas Duployez

9 joint publications

Christian Recher

9 joint publications

Raphaël Itzykson

6 joint publications

Laurène Fenwarth